MR restoration impacts cellular dynamics
COX10, a protoheme:heme-O-farnesyl transferase is indispensable for the biosynthesis of heme a, an elemental component of COX. Deficiency of COX10 results in marked impairment of COX and cellular respiration9; the molecular pathology of our previously published model in T cells (TCox10-/-). To restore MR specifically, we introduced a non-protonmotive ubiquinol oxidase (AOX) from Ciona intestinalis into TCox10-/- T cells. We engineered this novel mouse model by breeding TCox10-/- mice with counterparts constitutively expressing the Aox gene to generate TCox10-/-/Aox mice (Fig. 1A), with PCR and qPCR analysis confirming the genotypes and expression of Cox10 in the progeny (Fig. 1B and 1C). As AOX is an electron acceptor upstream of complex III (Fig. 1D), AOX-expressing cells can resist the effects of sodium azide, a toxin for COX, and continue respiration unaffected7, 10, 11. T cells derived from WT, Aox, TCox10-/-, and TCox10-/-/Aox mice were stimulated for 3 days with anti-CD3/CD28 and subjected to sodium azide. AOX-expressing cells maintained elevated oxygen consumption rates despite COX inhibition10, in contrast to the expected decline in WT and TCox10-/- T cells (Fig. 1E).
To survey how AOX-mediated restoration of MR may impact cellular dynamics, we performed an RNAseq experiment using T cells from WT, Aox, TCox10-/-, and TCox10-/-/Aox mice. Each genotype showed significant changes in gene expression relative to WT, or in TCox10-/-/Aox against TCox10-/- (Extended Data Fig. 1A and Supplemental Table 1). As these comparisons suggested considerable changes in gene expression across the four genotypes, we performed a weighted gene coexpression network analysis (WGCNA) to simultaneously compare them. Hierarchical clustering grouped the genes into 18 modules (Extended Data Fig. 1B). Examining the correlation of each module’s eigengene intercepts allowed us to identify which modules had gene expression perturbed in TCox10-/- and normalized by the introduction of AOX (Extended Data Fig. 1C). We selected four modules (turquoise, yellow, greenyellow, and midnightblue) that followed this pattern and used a heatmap of the normalized gene expression from each category to confirm the differences in expression across groups (Extended Data Fig. 1D). Overrepresentation analysis (ORA) of each of the modules indicated the main functions of the modules in these gene sets (Supplemental Table 2), which included cell cycle phase transition, apoptotic signaling, and T cell function (Fig. 1F). To further elucidate the functional implications of AOX-mediated restoration in MR, we proceeded to validate these gene expression changes through targeted biochemical and functional assays.
MR via AOX restores multiple aspects of mitochondrial function
After confirming the activity of AOX in T cells, we subsequently concentrated on mitochondrial function, given that this cellular organelle is the primary site of its activity. Transcriptional profiling of TCox10-/-/Aox mice revealed restoration of OXPHOS gene set enrichment, particularly gene sets associated with complex I (Extended Data Fig. 2A). Additionally, there were substantial enhancements in transcriptional signatures related to mtDNA metabolism and translation processes, as well as carbohydrate and nucleotide metabolism (Extended Data Fig. 2A and Supplemental Table 3). In TCox10-/-/Aox T cells, mitochondrial number (MitoGreen, Fig. 2A) reverted to WT levels. However, mtDNA content by qPCR (Fig. 2B) remained increased, suggesting that cells were still compensating for COX deficiency. Indeed, COX has been demonstrated to modulate mitochondrial genomic homeostasis,5 a process which may be independent of MR, as indicated by our results.
Based on its position in the ETC, we hypothesized that COX-mediated MR functions as a regulatory mechanism to mitigate the build-up of electron pressure within the ETC by acting as a safety valve. This effectively reduces the formation of reactive oxygen species (ROS). TCox10-/- T cells tend to have higher and more variable membrane potential (TMRE, Fig. 2C) suggesting an increase in electron build-up. TCox10-/-/Aox T cells show a normalization of mitochondrial membrane potential, similar to WT levels. This relief of electron build-up is further highlighted in cellular ROS. In TCox10-/- T cells, we observed elevated total cellular ROS (Fig. 2D), in the presence of diminished superoxide (Fig. 2E) and elevated hydrogen peroxide (Fig. 2F). These findings not only indicated oxidative stress, but also augmented superoxide dismutase activity (i.e., superoxide ® hydrogen peroxide). AOX, which bypasses complex III, a major source of ROS in T cells3, reduced ROS production, and hydrogen peroxide, indicating a restoration in redox balance. This was further supported by the AOX-mediated normalization of NAD+/NADH ratios, further signifying a restoration of cellular redox, and demonstrating the efficacy of AOX in alleviating electron pressure in the ETC (Fig. 2G).
We next turned to evaluating cellular respiration by extracellular flux analysis. OCR was markedly improved with AOX in CD4+ and CD8+ T cells with TCox10-/-/Aox cells exceeding that of WT (Fig. 2H and Extended Data Fig. 2B). To demonstrate that the observed increase in OCR did not relate to COX activity, we used a targeted substrate (N′-tetramethyl-para-phenylene-diamine (TMPD)). COX-mediated respiration remained low in TCox10-/-/Aox T cells, suggesting that AOX does not enhance COX activity but instead functions independently (Fig. 2I). AOX addition also resulted in the augmentation of total cellular ATP production, although not to WT levels (Fig. 2J). Therefore, reestablishing by AOX cellular respiration reduces oxidative stress, and improves ATP production and cellular redox balance, restoring mitochondrial homeostasis, ultimately revealing insights into the role of COX-dependent respiration in the T cell processes.
MR offloads upstream carriers of chemical energy during metabolic reprogramming
Based on our finding that MR reduces electron buildup and restores the cellular redox state (i.e., ROS and NAD+/NADH), we next asked whether this function also serves as a safety valve for upstream metabolic processes. The TCA cycle and glycolysis are integral to T cell metabolic reprogramming2 and are dependent on the redox state of the cell. To better understand the role of MR in supporting upstream metabolic function, we employed stable isotope tracing experiments during metabolic reprogramming in 24 hour activated T cells, as above.
Glutamine is an anaplerotic amino acid in the TCA cycle, generating reducing equivalents that can drive OXPHOS12, 13. Previously, we demonstrated that activated TCox10-/- T cells develop glutamine addiction with increased incorporation of this amino acid into the TCA cycle4. In TCox10-/-/Aox T cells, we observed that the incorporation of 13C-glutamine carbons into downstream metabolites (Fig. 3A), including fumarate (M + 4), malate (M + 4), and aspartate (M + 4), decreased, returning to WT levels (Fig. 3B) and indicating the resolution of glutamine addiction. Citrate (M + 4 and M + 2) concentrations were also improved, signaling a reactivation of cycling dynamics of the TCA (Fig. 3C).
TCox10-/- T cells also demonstrated depressed glycolysis following activation4, driven in part by negative enrichment and downregulation of glycolytic pathway genes (Extended Data Fig. 2A). To study glycolysis, we first examined glucose transport, a process that is upregulated in T cells during metabolic reprogramming14. While glucose transport via 2-NDBG uptake was suppressed in activated TCox10-/- T cells, this process was reestablished in TCox10-/-/Aox CD4+ and CD8+ T cells (Fig. 3D). With enhanced glucose transport in TCox10-/-/Aox T cells, we next focused on the fate of glucose carbons using stable isotope tracing with 13C-glucose (Fig. 3E). Glucose free media was supplemented with 13C-glucose and T cells were stimulated for 24 hours as above. TCox10-/-/Aox T cells displayed a normalized uptake of 13C into pyruvate (M + 3) and lactate (M + 3), signaling a restoration of glycolytic activity (Fig. 3F). Interestingly, glycolytic gene expression is not restored in TCox10-/-/Aox T cells (Extended Data Fig. 2A), suggesting that this enhancement occurs through post-transcriptional mechanisms. We next asked whether the conversion of glucose into the TCA cycle via pyruvate also returned. Indeed, we observed elevated 13C incorporation into citrate (M + 2) signifying enhanced influx of glucose-derived carbons into the TCA cycle (Fig. 3G). The enrichment of downstream TCA cycle intermediates—succinate, fumarate, malate, and aspartate (all M + 2)—further confirmed this restoration (Fig. 3H). An enhancement in the isotopic enrichment of citrate (M + 4) also highlighted the resumption of cycling of the TCA (Fig. 3I). Thus, by enabling the flow of electrons within the ETC, MR reduces the upstream electron pressure from glutaminolysis and glycolysis concomitantly maintaining TCA cycle function in T cells. Our results also suggest that a significant portion of glucose is eventually oxidized in the mitochondria during T cell activation.
MR abrogates apoptosis
In our previous study, we demonstrated that COX mediates apoptosis in activated T cells during the phase of proliferation4. We next asked whether the restoration of MR could restore cellular viability. Building on our previous findings, alterations in apoptosis were disentangled by mapping TCox10-/-/Aox versus TCox10-/- log2 fold changes (L2FCs) from our RNAseq onto the KEGG apoptosis pathway (mmu04210) (Extended Data Fig. 3A). While multiple pro-apoptotic and pro-survival genes were upregulated in TCox10-/- T Cells, interestingly, elevated expression of extrinsic activators Fas, FasL, Perf1, and Tradd was reversed by AOX. Apoptosis was measured in T cells by live/dead dye and Annexin V staining (Fig. 4A), revealing a reduction in apoptotic TCox10-/-/Aox CD4+ and CD8+ T cells by approximately 50% (Fig. 4B). To investigate potential mechanisms underlying the reduction in apoptosis, we assessed caspase 3 activation, a common pathway for both intrinsic and extrinsic apoptosis. Caspase 3 activation was abnormally elevated in TCox10-/- T cells and decreased in TCox10-/-/Aox T cells (Fig. 4C). We also observed similar trends in specific apoptotic pathways, showing amelioration of both caspase 8 (i.e., extrinsic pathway, Fig. 4D) and caspase 9 (i.e., intrinsic pathway, Fig. 4E) activation in TCox10-/-/Aox T cells. Since we observed more consistent increased expression of Caspase 8 and given our RNAseq results (Extended Data Fig. 3A and Supplemental Table 1), we further examined activation of the extrinsic pathway by quantifying Fas and FasL (Figs. 4F and 4G). Expression of both proteins were increased in TCox10-/- T cells and reduced with AOX expression. To probe the activity of this pathway in vitro, we used anti-FasL antibodies on WT and TCox10-/- CD8+ and CD4+ T cells. This intervention significantly increased the viability of TCox10-/- T cells (Extended Data Fig. 3B) indicating a major role for this pathway in COX mediated apoptosis. However, blocking FasL did not improve proliferation as reflected by the retention of Cell Trace Violet (CTV, Extended Data Fig. 3C) underscoring the importance of maintaining MR. Therefore, these data support that COX-mediated apoptosis involves the external pathway and is secondary to MR dysfunction in T cells.
MR sustains T cell function in vitro
Significant deficiencies in T cell differentiation and function result from COX deficiency4. With a re-establishment of metabolic reprogramming and a suppression of apoptosis by AOX, we next evaluated core functions in TCox10-/-/Aox T cells in vitro. Following metabolic reprogramming, T cells engage in robust proliferation. To examine the impact of MR on proliferation, we loaded T cells with CTV and activated for 3 days as above. TCox10-/-/Aox T cell proliferation matched WT, even when challenged with sodium azide (Fig. 5A), indicating that the AOX-mediated MR could support proliferation. Flow cytometry analysis revealed that activated TCox10-/- T cells displayed cell surface markers indicative of a heightened activation state (CD44, CD69, Fig. 5B) while TCox10-/-/Aox cells more closely aligned to WT.
To evaluate the role of MR in T cell differentiation, we produced helper T cells (Th) in TCox10-/-/Aox cells in vitro, following a standardized protocol (Fig. 5C). We found that TCox10-/-/Aox T cells acquired differentiation capacities, particularly in Th1 and Th17 subsets, approximating the patterns observed in WT cells (Fig. 5D). Regulatory T cells (Foxp3+, Treg), were decreased in AOX expressing cells, signifying a more complex relationship between mitochondrial function and their differentiation.
We next evaluated T cell effector (Teff) and memory (Tmem) differentiation in vitro, essential processes for sustained immune protection (Fig. 5E). In TCox10-/- T cells, memory and effector cell differentiation were previously unachievable due to overwhelming apoptosis and death. The re-introduction of MR facilitated the generation of both Teff and Tmem. These cells exhibited improvements in the expression of phenotypic markers of differentiation for their respective cell types, albeit incompletely (Fig. 5F). To assess the functionality of Teff cells, we stained for the expression of granzyme, an essential molecule for cytolytic activity. Granzyme levels in TCox10-/-/Aox matched those in WT and Aox controls, and their killing activity was similarly robust, confirming that the cytotoxic capabilities were fully present (Figs. 5G and 5H). Given the lack of a robust in vitro assay for memory function, we performed RNAseq analysis on TCox10-/-/Aox differentiated memory T cells (Fig. 5I and Supplemental Table 4). Despite significant differences in their transcriptional profiles, the expression of core genes involved in effector memory (Tem) and central memory (Tcm) differentiation was largely similar between TCox10-/-/Aox and WT cells, with the notable exception of Eomes. This indicates that while TCox10-/-/Aox memory T cells exhibit broad transcriptional changes, essential pathways for memory differentiation mostly remain intact. All things considered, our findings in TCox10-/-/Aox T cells underscore that maintaining MR, the core function of COX, is essential for T cell differentiation. Following these encouraging results in Teff and Tmem, it became imperative to further assess the functional capabilities of these cells in a physiologically relevant setting (i.e., in vivo).
MR is critical for T cells in vivo
T cells orchestrate and execute the immune response through cytokine production or direct cellular interactions, serving as both regulators and effectors. A core function of T cells is maintaining immune memory, ensuring a rapid and effective response to previously encountered antigens. To evaluate how MR may support these diverse abilities, we studied TCox10-/-/Aox T cell development and function in vivo. As a secondary lymphoid organ, the spleen serves as a microenvironment for immune interactions, providing a specialized niche where immune cells such as T cells, B cells, and macrophages coordinate responses. In the spleens of both TCox10-/- and TCox10-/-/Aox mice, we observed a tendency for elevated B cells and macrophages, signifying imbalances between splenic resident cells (Figs. 6A and 6B). Despite the AOX, decreased quantities of both CD4+ and CD8+ T cells persisted in the spleens of TCox10-/-/Aox mice (Fig. 6C). This reduction signals that AOX, while improving some aspects of T cell function, cannot fully restore T cell populations to normal levels. With these numeric perturbations in splenic populations, we next measured T-dependent B cell responses through immunization with 2,4,6-Trinitrophenyl-Chicken Gamma Globulin (TNP-CGG). The results were promising: unlike TCox10-/-, TCox10-/-/Aox mice mounted effective primary (2 weeks) and secondary (5 weeks) B cell responses, illustrating that MR enhances the supportive role of T cells (Fig. 6D).
Mitochondria are integral to the development of T cell memory by providing the necessary energy and signaling pathways that support their long-term survival and rapid response capabilities15. To assess the requirement of MR for development of memory T cells, we conducted an in vivo challenge with influenza virus (Fig. 6E). Mice were first immunized with influenza A/X31 (X31, H3N2) followed with influenza A/PR/8 (PR8, H1N1) challenge at 5 weeks. Both immunization and challenge were conducted using inhalation. Our experimental design, based on a switch in viral isotypes (X-31→PR8), eliminates the memory humoral responses, allowing us to focus on T cells. To demonstrate the generation of influenza-specific memory, we stained T cells with tetramers against two T cell antigenic determinants, the nucleoprotein (NP366–374, H2Db) and the acid polymerase (PA224–233, H2Db)16, 17. The primary CD8+ T cell response to both strains is dominated by naïve T-cell recognition of both determinants. However, the NP366–374 response dominates the secondary response in X-31→PR8 isotype switch challenge. TCox10-/- mice showed a limited ability to generate memory cells, while TCox10-/-/Aox mice successfully generated memory T cells at levels comparable to WT (Fig. 6F). The most direct evidence of functional recovery came from viral load assessments, where TCox10-/-/Aox mice exhibited viral loads not significantly different from WT, significantly lower than those seen in TCox10-/- mice (Fig. 6G). This dramatic reduction in viral load highlights the restored antiviral efficacy of T cells in AOX-expressing mice. Lastly, to ascertain whether the improvements were cell-autonomous, we conducted adoptive transfer experiments using bone marrow from WT, Aox, TCox10-/-, and TCox10-/-/Aox mice. We found that mice reconstituted with TCox10-/-/Aox bone marrow could produce added viral specific T cells (Fig. 6H) and reduce viral load to levels similar to WT (Fig. 6I), demonstrating that the benefits of AOX were indeed cell-autonomous.